A new clinical study to determine how people with rheumatoid arthritis evaluate improvements in disease symptoms will be carried out by NIAMS, part of the NIH. The study will examine how much of an improvement in pain, stiffness, function and other symptoms is needed before patients consider the change important. The Clinically Important Changes in Rheumatoid Arthritis study will recruit 300 people 18 years of age or older who have been diagnosed with rheumatoid arthritis. Researchers are particularly interested in patients who are currently being treated with:

• prednisone
• methotrexate
• Arava
• Remicade
• Enbrel

Related Resources - Rheumatoid Arthritis

• Guide to Rheumatoid Arthritis
• Rheumatoid Arthritis Screening Quiz
• Test Your Knowledge: Rheumatoid Arthritis